Cardiovascular safety of lumiracoxib: A meta-analysis of all randomized controlled trials ≥1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis
Matchaba, Patrice, Gitton, Xavier, Krammer, Gerhard, Ehrsam, Elena, Sloan, Victor Schorr, Olson, Melvin, Mellein, Bernhard, Hoexter, Godehard, Orloff, John, Garaud, Jean-Jacques
Published in Clinical therapeutics (01.08.2005)
Published in Clinical therapeutics (01.08.2005)
Get full text
Journal Article
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)
Hacke, W, Kaste, M, Fieschi, C, Toni, D, Lesaffre, E, von Kummer, R, Boysen, G, Bluhmki, E, Höxter, G, Mahagne, M H
Published in JAMA : the journal of the American Medical Association (04.10.1995)
Published in JAMA : the journal of the American Medical Association (04.10.1995)
Get more information
Journal Article
Gastroduodenal safety and tolerability of lumiracoxib compared with Ibuprofen and celecoxib in patients with osteoarthritis
Hawkey, Christopher C, Svoboda, Petr, Fiedorowicz-Fabrycy, Irena F, Nasonov, Evgeny L, Pikhlak, Eduard G, Cousin, Marc, Gitton, Xavier, Hoexter, Godehard
Published in Journal of rheumatology (01.09.2004)
Get more information
Published in Journal of rheumatology (01.09.2004)
Journal Article